80 related articles for article (PubMed ID: 30816566)
21. The inhibitor of differentiation isoform Id1b, generated by alternative splicing, maintains cell quiescence and confers self-renewal and cancer stem cell-like properties.
Manrique I; Nguewa P; Bleau AM; Nistal-Villan E; Lopez I; Villalba M; Gil-Bazo I; Calvo A
Cancer Lett; 2015 Jan; 356(2 Pt B):899-909. PubMed ID: 25449776
[TBL] [Abstract][Full Text] [Related]
22. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM
Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046
[TBL] [Abstract][Full Text] [Related]
23. Molecular iodine inhibits the expression of stemness markers on cancer stem-like cells of established cell lines derived from cervical cancer.
Bigoni-Ordóñez GD; Ortiz-Sánchez E; Rosendo-Chalma P; Valencia-González HA; Aceves C; García-Carrancá A
BMC Cancer; 2018 Sep; 18(1):928. PubMed ID: 30257666
[TBL] [Abstract][Full Text] [Related]
24. miR-143 and miR-145 inhibit stem cell characteristics of PC-3 prostate cancer cells.
Huang S; Guo W; Tang Y; Ren D; Zou X; Peng X
Oncol Rep; 2012 Nov; 28(5):1831-7. PubMed ID: 22948942
[TBL] [Abstract][Full Text] [Related]
25. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
26. Jak2-Stat5a/b Signaling Induces Epithelial-to-Mesenchymal Transition and Stem-Like Cell Properties in Prostate Cancer.
Talati PG; Gu L; Ellsworth EM; Girondo MA; Trerotola M; Hoang DT; Leiby B; Dagvadorj A; McCue PA; Lallas CD; Trabulsi EJ; Gomella L; Aplin AE; Languino L; Fatatis A; Rui H; Nevalainen MT
Am J Pathol; 2015 Sep; 185(9):2505-22. PubMed ID: 26362718
[TBL] [Abstract][Full Text] [Related]
27. Suppressive Effect of Delta-Tocotrienol on Hypoxia Adaptation of Prostate Cancer Stem-like Cells.
Kaneko S; Sato C; Shiozawa N; Sato A; Sato H; Virgona N; Yano T
Anticancer Res; 2018 Mar; 38(3):1391-1399. PubMed ID: 29491063
[TBL] [Abstract][Full Text] [Related]
28. Co-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cells.
Ke XY; Lin Ng VW; Gao SJ; Tong YW; Hedrick JL; Yang YY
Biomaterials; 2014 Jan; 35(3):1096-108. PubMed ID: 24183698
[TBL] [Abstract][Full Text] [Related]
29. Atorvastatin inhibited Rho-associated kinase 1 (ROCK1) and focal adhesion kinase (FAK) mediated adhesion and differentiation of CD133+CD44+ prostate cancer stem cells.
Rentala S; Chintala R; Guda M; Chintala M; Komarraju AL; Mangamoori LN
Biochem Biophys Res Commun; 2013 Nov; 441(3):586-92. PubMed ID: 24177008
[TBL] [Abstract][Full Text] [Related]
30. Phosphodiesterase 5/protein kinase G signal governs stemness of prostate cancer stem cells through Hippo pathway.
Liu N; Mei L; Fan X; Tang C; Ji X; Hu X; Shi W; Qian Y; Hussain M; Wu J; Wang C; Lin S; Wu X
Cancer Lett; 2016 Aug; 378(1):38-50. PubMed ID: 27179930
[TBL] [Abstract][Full Text] [Related]
31. Enrichment of putative prostate cancer stem cells after androgen deprivation: upregulation of pluripotency transactivators concurs with resistance to androgen deprivation in LNCaP cell lines.
Seiler D; Zheng J; Liu G; Wang S; Yamashiro J; Reiter RE; Huang J; Zeng G
Prostate; 2013 Sep; 73(13):1378-90. PubMed ID: 23728788
[TBL] [Abstract][Full Text] [Related]
32. Salinomycin Exerts Anticancer Effects on PC-3 Cells and PC-3-Derived Cancer Stem Cells In Vitro and In Vivo.
Zhang Y; Liu L; Li F; Wu T; Jiang H; Jiang X; Du X; Wang Y
Biomed Res Int; 2017; 2017():4101653. PubMed ID: 28676857
[TBL] [Abstract][Full Text] [Related]
33. Gamma-tocotrienol as an effective agent in targeting prostate cancer stem cell-like population.
Luk SU; Yap WN; Chiu YT; Lee DT; Ma S; Lee TK; Vasireddy RS; Wong YC; Ching YP; Nelson C; Yap YL; Ling MT
Int J Cancer; 2011 May; 128(9):2182-91. PubMed ID: 20617516
[TBL] [Abstract][Full Text] [Related]
34. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice.
Song X; Zhu S; Xie Y; Liu J; Sun L; Zeng D; Wang P; Ma X; Kroemer G; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Kang R; Tang D
Gastroenterology; 2018 Apr; 154(5):1480-1493. PubMed ID: 29248440
[TBL] [Abstract][Full Text] [Related]
35. Identification of thioridazine, an antipsychotic drug, as an antiglioblastoma and anticancer stem cell agent using public gene expression data.
Cheng HW; Liang YH; Kuo YL; Chuu CP; Lin CY; Lee MH; Wu AT; Yeh CT; Chen EI; Whang-Peng J; Su CL; Huang CY
Cell Death Dis; 2015 May; 6(5):e1753. PubMed ID: 25950483
[TBL] [Abstract][Full Text] [Related]
36. Exendin-4 enhances radiation response of prostate cancer.
He W; Li J
Prostate; 2018 Nov; 78(15):1125-1133. PubMed ID: 30009503
[TBL] [Abstract][Full Text] [Related]
37. Chemopreventive effect of PSP through targeting of prostate cancer stem cell-like population.
Luk SU; Lee TK; Liu J; Lee DT; Chiu YT; Ma S; Ng IO; Wong YC; Chan FL; Ling MT
PLoS One; 2011; 6(5):e19804. PubMed ID: 21603625
[TBL] [Abstract][Full Text] [Related]
38. The identification of the biological characteristics of human ovarian cancer stem cells.
Yan HC; Fang LS; Xu J; Qiu YY; Lin XM; Huang HX; Han QY
Eur Rev Med Pharmacol Sci; 2014 Nov; 18(22):3497-503. PubMed ID: 25491627
[TBL] [Abstract][Full Text] [Related]
39. Wild-type p53 suppresses the epithelial-mesenchymal transition and stemness in PC-3 prostate cancer cells by modulating miR‑145.
Ren D; Wang M; Guo W; Zhao X; Tu X; Huang S; Zou X; Peng X
Int J Oncol; 2013 Apr; 42(4):1473-81. PubMed ID: 23404342
[TBL] [Abstract][Full Text] [Related]
40. Differentiation therapy: targeting human renal cancer stem cells with interleukin 15.
Azzi S; Bruno S; Giron-Michel J; Clay D; Devocelle A; Croce M; Ferrini S; Chouaib S; Vazquez A; Charpentier B; Camussi G; Azzarone B; Eid P
J Natl Cancer Inst; 2011 Dec; 103(24):1884-98. PubMed ID: 22043039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]